[Corrections] Correction to Lancet Infect Dis 2026; 26: 522–34
Summary
Razzini JL, Giné-Vázquez I, Jin J, et al. Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study. Lancet Infect Dis 2026; 26: 522–34—In table 2 of this Article, the relative change in weekly incidence of all-cause first recurrent hospitalisation up to 1…
Razzini JL, Giné-Vázquez I, Jin J, et al. Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study. Lancet Infect Dis 2026; 26: 522–34—In table 2 of this Article, the relative change in weekly incidence of all-cause first recurrent hospitalisation up to 18 months follow-up should have been −16·0% (–27·8 to −2·3). This correction has been made to the online version as of April 22, 2026, and the printed version is correct.